Stephen Gately

Summary

Affiliation: Pharmacia Corporation
Country: USA

Publications

  1. ncbi request reprint Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis
    Stephen Gately
    NeoPharm Inc, Department of Translational Medicine, Lake Forest, Ill, USA
    Prog Exp Tumor Res 37:179-92. 2003
  2. ncbi request reprint Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy
    Stephen Gately
    Department of Translational Medicine, NeoPharm Inc, 150 Field Drive, Suite 195, Lake Forest, IL 60045, USA
    Semin Oncol 31:2-11. 2004
  3. ncbi request reprint Tumor production of angiostatin is enhanced after exposure to TNF-alpha
    Helena J Mauceri
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Cancer 97:410-5. 2002

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis
    Stephen Gately
    NeoPharm Inc, Department of Translational Medicine, Lake Forest, Ill, USA
    Prog Exp Tumor Res 37:179-92. 2003
    ..The continued dependence on angiogenesis for later stages of tumorigenesis suggests that COX-2 inhibitors also will have clinical utility in the management of advanced cancers...
  2. ncbi request reprint Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy
    Stephen Gately
    Department of Translational Medicine, NeoPharm Inc, 150 Field Drive, Suite 195, Lake Forest, IL 60045, USA
    Semin Oncol 31:2-11. 2004
    ....
  3. ncbi request reprint Tumor production of angiostatin is enhanced after exposure to TNF-alpha
    Helena J Mauceri
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Cancer 97:410-5. 2002
    ..These studies support a model in which the antiangiogenic effects of TNF-alpha on the tumor microvasculature are mediated by generation of angiostatin...